Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M, Iwamoto T, Matsuoka J, Nogami T, Motoki T, Shien T, Taira N, Niikura N, Hayashi N, Ohtani S, Higaki K, Fujiwara T, Doihara H, Symmans WF, Pusztai L. Itoh M, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z. Epub 2013 Dec 15. Breast Cancer Res Treat. 2014. PMID: 24337596 Free article.
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.
Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J. Sugiu K, et al. Among authors: matsuoka j. Acta Med Okayama. 2015;69(5):291-9. doi: 10.18926/AMO/53675. Acta Med Okayama. 2015. PMID: 26490026 Free article. Clinical Trial.
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
Iwamoto T, Kumamaru H, Miyata H, Tomotaki A, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Matsuoka J, Doihara H, Kinoshita T, Nakamura S, Tokuda Y. Iwamoto T, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2016 Apr;156(3):485-494. doi: 10.1007/s10549-016-3770-7. Epub 2016 Apr 5. Breast Cancer Res Treat. 2016. PMID: 27048417 Free PMC article.
Current Multidisciplinary Approach to Fertility Preservation for Breast Cancer Patients.
Takahashi Y, Shien T, Sakamoto A, Tsuyumu Y, Yoshioka R, Uno M, Hatono M, Kochi M, Kawada K, Tsukioki T, Iwamoto T, Ikeda H, Taira N, Matsuoka J, Nakatsuka M, Doihara H. Takahashi Y, et al. Among authors: matsuoka j. Acta Med Okayama. 2018 Apr;72(2):137-142. doi: 10.18926/AMO/55854. Acta Med Okayama. 2018. PMID: 29674762 Free article.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S. Takahashi Y, et al. Among authors: matsuoka j. Clin Breast Cancer. 2020 Apr;20(2):117-124.e4. doi: 10.1016/j.clbc.2019.07.001. Epub 2019 Sep 9. Clin Breast Cancer. 2020. PMID: 31570267 Free article.
250 results